XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Revenue $ 4,192,000 $ 9,265,000 $ 4,843,000
Cost of revenue 8,447,000 5,833,000 2,741,000
Gross profit (loss) (4,255,000) 3,432,000 2,102,000
Research and development expenses 109,587,000 74,768,000 20,497,000
General and administrative expenses 31,070,000 28,407,000 5,664,000
Selling and marketing expenses 7,043,000 4,443,000 1,682,000
Total operating expenses 147,700,000 107,618,000 27,843,000
Operating loss (151,955,000) (104,186,000) (25,741,000)
Interest income 3,707,000 372,000 195,000
Other income (expense), net 943,000 1,936,000 (24,000)
Net loss before income taxes (147,305,000) (101,878,000) (25,570,000)
Income taxes provision 0 0 0
Net loss (147,305,000) (101,878,000) (25,570,000)
Unrealized loss on available-for-sale securities (3,061,000) (524,000) 0
Total comprehensive loss $ (150,366,000) $ (102,402,000) $ (25,570,000)
Net loss per share, basic $ (0.68) $ (0.51) $ (0.18)
Net loss per share, diluted $ (0.68) $ (0.51) $ (0.18)
Weighted-average shares used in computing net loss per share, basic 217,307,896 200,849,663 141,741,752
Weighted-average shares used in computing net loss per share, diluted 217,307,896 200,849,663 141,741,752